Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genes Have Evolved to Minimize Translation Errors

By Biotechdaily staff writers
Posted on 06 Aug 2008
New research suggests that the major detrimental effect of some mutations, especially in long-lived cells such as neurons, is the accumulation of toxic, misfolded proteins. More...
This conclusion is at odds with the conventional understanding that the damage caused by mutations is linked to the loss of functional proteins.

Many protein molecules must fold into a precise three-dimensional configuration to become biologically active, and mistakes arising from mutation can cause misfolding, which can be toxic. For example, misfolded proteins are known to accumulate in neurons and are critically linked to fatal disorders such as amyotrophic lateral sclerosis (ALS). Yet, research would suggest that mistakes due to mutations arise in nearly 20% of the molecules produced by any given cell. To understand how genes evolve, it is necessary to understand how they adapt to this rather slipshod behavior.

In the current study investigators at the University of Texas (Austin, USA) and Harvard University (Cambridge, MA, USA) performed gene analysis of organisms as diverse as humans, mice, fruit flies, worms, yeast, and Escherichia coli. They reported in the July 25, 2008, edition of the journal Cell that natural selection has fostered the evolution of genes that minimize the effects of errors in translation such as misfolding.

"It has long been believed that the main force of natural selection on protein-coding genes is the need to maintain a working protein,” explained senior author Dr. Alan Drummond, a Bauer Fellow in the FAS center for systems biology at Harvard University. "Our work suggests that another force may be equally important: the need to avoid misfolded proteins resulting from errors in translation.”


Related Links:
University of Texas
Harvard University

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.